Abstract
Large-scale variations of the human genome can be produced by losses or gains of whole chromosomes (aneuploidy). In contrast to DNA sequences variations at subchromosomal level (single nucleotide polymorphisms, short tandem repeat variations) or interindividual subtle chromosome region changes (deletions, duplications, large-scale copynumber variants, fragile sites), aneuploidy simultaneously involves hundreds or even thousands of genes and, therefore, dramatically affects functional genome activity. Aneuploidy originates from either meiotic or mitotic chromosome instability and, in some instances, manifests as somatic chromosomal mosaicism. Although the real incidence of mosaic aneuploidy in somatic human tissues remains to be determined, one can suppose an overlooked fraction of cells with unshared genomes due to large-scale genomic alterations among 1014 cells forming the human body. Intercellular differences in chromosome number can be considered an overlooked type of structural and functional genome variations, which produce genetic mosaicism. This review refers to somatic chromosomal mosaicism and aims to describe its mechanisms and consequences. Moreover, the effect of somatic chromosomal mosaicism on both interindividual and intercellular diversity as well as human diseases is discussed. Finally, since the identification of these genomic variations faces numerous difficulties, we found pertinent to describe available approaches towards the detection of chromosomal mosaicism in human somatic tissues.
Keywords: Somatic chromosomal mosaicism (SCM), intercellular genomic variations, intracellular genomic instability, aneuploidy, polyploidy, neuropsychiatric diseases, fluorescence in situ hybridization (FISH)
Current Genomics
Title: Intercellular Genomic (Chromosomal) Variations Resulting in Somatic Mosaicism: Mechanisms and Consequences
Volume: 7 Issue: 7
Author(s): I. Y. Iourov, S. G. Vorsanova and Y. B. Yurov
Affiliation:
Keywords: Somatic chromosomal mosaicism (SCM), intercellular genomic variations, intracellular genomic instability, aneuploidy, polyploidy, neuropsychiatric diseases, fluorescence in situ hybridization (FISH)
Abstract: Large-scale variations of the human genome can be produced by losses or gains of whole chromosomes (aneuploidy). In contrast to DNA sequences variations at subchromosomal level (single nucleotide polymorphisms, short tandem repeat variations) or interindividual subtle chromosome region changes (deletions, duplications, large-scale copynumber variants, fragile sites), aneuploidy simultaneously involves hundreds or even thousands of genes and, therefore, dramatically affects functional genome activity. Aneuploidy originates from either meiotic or mitotic chromosome instability and, in some instances, manifests as somatic chromosomal mosaicism. Although the real incidence of mosaic aneuploidy in somatic human tissues remains to be determined, one can suppose an overlooked fraction of cells with unshared genomes due to large-scale genomic alterations among 1014 cells forming the human body. Intercellular differences in chromosome number can be considered an overlooked type of structural and functional genome variations, which produce genetic mosaicism. This review refers to somatic chromosomal mosaicism and aims to describe its mechanisms and consequences. Moreover, the effect of somatic chromosomal mosaicism on both interindividual and intercellular diversity as well as human diseases is discussed. Finally, since the identification of these genomic variations faces numerous difficulties, we found pertinent to describe available approaches towards the detection of chromosomal mosaicism in human somatic tissues.
Export Options
About this article
Cite this article as:
Iourov Y. I., Vorsanova G. S. and Yurov B. Y., Intercellular Genomic (Chromosomal) Variations Resulting in Somatic Mosaicism: Mechanisms and Consequences, Current Genomics 2006; 7 (7) . https://dx.doi.org/10.2174/138920206779116756
DOI https://dx.doi.org/10.2174/138920206779116756 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Epigenetics in Cystic Fibrosis: Epigenetic Targeting of a Genetic Disease
Current Drug Targets Targeting Oncogenes and Tumor Suppressors genes to Mitigate Chemoresistance
Current Cancer Drug Targets 4-aryl/heteroaryl-4H-fused Pyrans as Anti-proliferative Agents: Design, Synthesis and Biological Evaluation
Anti-Cancer Agents in Medicinal Chemistry Geldanamycin, Radicicol, and Chimeric Inhibitors of the Hsp90 Nterminal ATP Binding Site
Current Topics in Medicinal Chemistry Antineovascular Agents in the Treatment of Eye Diseases
Current Pharmaceutical Design Angiogenesis and Metastasis Inhibitors for the Treatment of Malignant Melanoma
Mini-Reviews in Medicinal Chemistry High Mobility Group Box 1 Protein as a Potential Drug Target for Infection- and Injury-Elicited Inflammation
Inflammation & Allergy - Drug Targets (Discontinued) Promoters and Control Elements: Designing Expression Cassettes for Gene Therapy
Current Gene Therapy Role of Advanced Glycation End Products (AGEs) and Oxidative Stress in Diabetic Retinopathy
Current Pharmaceutical Design HPV-mediated Cervical Cancer: A Systematic Review on Immunological Basis, Molecular Biology, and Immune Evasion Mechanisms
Current Drug Targets Cancer Stem Cells with Overexpression of Neuronal Markers Enhance Chemoresistance and Invasion in Retinoblastoma
Current Cancer Drug Targets A Simple High Efficiency Intra-Islet Transduction Protocol Using Lentiviral Vectors
Current Gene Therapy Caspase-Independent Pathways of Programmed Cell Death: The Unraveling of New Targets of Cancer Therapy?
Current Cancer Drug Targets Deregulation of PI3K/Akt/mTOR Signaling Pathways by Isoflavones and its Implication in Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Gene Therapy Strategies in Prostate Cancer
Current Gene Therapy E2F1 and NF-κB: Key Mediators of Inflammation-associated Cancers and Potential Therapeutic Targets
Current Cancer Drug Targets Advances in Ocular Iontophoresis Research
Recent Patents on Nanomedicine Episomal Vectors for Gene Therapy
Current Gene Therapy NCRNA Combined Therapy as Future Treatment Option for Cancer
Current Pharmaceutical Design Nitrogen Mustards as Anticancer Chemotherapies: Historic Perspective, Current Developments and Future Trends
Current Topics in Medicinal Chemistry